Work

Development and internal validation of VA-BLED for 1-year esophageal variceal bleeding risk in cirrhosis

Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND AND AIMS: Esophageal variceal bleeding is a life-threatening complication of cirrhosis, yet current risk stratification targets portal hypertension stage and endoscopic stigmata instead of short-term bleeding probability. We evaluated whether a simple score built from routinely available variables could stratify 1-year esophageal variceal bleeding risk. METHODS: We developed and internally validated two multivariable logistic models in a retrospective outcome-balanced cohort of 108 patients with esophageal varices (54 variceal bleeding, 54 no bleeding). VA-BLED BASE incorporated Child-Pugh score, normalized alanine aminotransferase, and current alcohol use. VA-BLED HISTORY additionally incorporated previous bleeding. Performance was assessed from out-of-fold predictions using discrimination, calibration, and decision curve analysis. RESULTS: VA-BLED BASE achieved an out-of-fold area under the receiver operating characteristic curve of 0.732 (95% confidence interval, 0.635-0.827), which increased to 0.798 (95% confidence interval, 0.705-0.883) when previous bleeding history was included. Both models provided net benefit across clinically plausible threshold probabilities. At an assumed annual bleeding prevalence of 10%, VA-BLED BASE generated low-, intermediate-, and high-risk zones, whereas VA-BLED HISTORY functioned primarily as a high-risk enrichment model. CONCLUSIONS: In this proof-of-concept development study, VA-BLED BASE and VA-BLED HISTORY stratified 1-year EVB risk using routinely available clinical variables and identified subgroups enriched for bleeding events. External validation in cohort-design populations is required before clinical application.
Source: PLoS ONE
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,382
OpenAlex ID: W7234166102
FWCI:
Cites: 36
Cited by:
Related to: 10
Parts: 13